Strategic Forecast for the Calcitonin Injection Industry: Market Outlook 2025-2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Calcitonin Injection Market Size Growth Forecast: What to Expect by 2025?
In recent times, the market for calcitonin injections has experienced substantial growth. The size of the market is projected to rise from $0.67 billion in 2024 to $0.73 billion in 2025, with a compound annual growth rate (CAGR) of 8.5%. Factors such as increasing cases of osteoporosis, growing awareness about bone health, broader options for postmenopausal treatments, accessibility of government healthcare subsidies, and an increase in the older population are contributing to the growth witnessed in the historic period.

How Will the Calcitonin Injection Market Size Evolve and Grow by 2029?
In the next few years, the calcitonin injection market is projected to witness robust growth, escalating to $0.99 billion by 2029, reflecting a compound annual growth rate (CAGR) of 8.2%. This expansion during the prediction period is credited to the surging demand for treatments, the emergence of biosimilar competitors, increased demand in nascent markets, a shift towards personalized healthcare, and extensive research into alternative uses for calcitonin. The forecast period will also observe significant trends such as progress in intranasal and injectable delivery methods, advanced formulations with prolonged half-lives, the creation of biosimilar calcitonin goods, breakthroughs in osteoporosis treatment approaches, and advancements in diagnostic equipment.

View the full report here:
https://www.thebusinessresearchcompany.com/report/calcitonin-injection-global-market-report

What Drivers Are Propelling the Growth of Calcitonin Injection Market Forward?
The upsurge in osteoporosis rates is anticipated to fuel the calcitonin injection market expansion. Osteoporosis, a condition typified by a decline in bone density and heightened risk of fractures, predominantly impacts aged individuals, specifically postmenopausal women. The growing incidence of osteoporosis can be attributed to greater life expectancies, which result in inevitable loss of bone density and elevated disease risk. Calcitonin injection plays a significant role in osteoporosis management by controlling calcium levels and decelerating bone loss, hence acting efficiently in maintaining bone density. These injections, which are simple to administer, facilitate targeted treatment, enhance patient adherence, and minimize the risk of fractures. For example, per the Australian Institute of Health and Welfare in June 2024, 853,600 people (or 3.4%) in Australia were living with osteoporosis or osteopenia in 2022, leading to 2,659 deaths, or 1.4% of all deaths. Consequently, the rising prevalence of osteoporosis is spurring the expansion of the calcitonin injection market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24490&type=smp

Which Emerging Trends Are Transforming the Calcitonin Injection Market in 2025?
Leading firms in the calcitonin injection market are channeling their efforts into the creation of groundbreaking products such as USP synthetic injections to enhance therapeutic results and ameliorate patient health outcomes. USP Synthetic Injections are medicines meant for injection, comprising synthetically crafted active ingredients which comply with the rigorous standards for quality, purity, potency, and identity as established by the United States Pharmacopeia (USP). These injections are produced under tightly controlled environments to guarantee that they're safe and therapeutically effective. For instance, February 2025 saw Fresenius Kabi, a pharmaceutical firm based in Germany, bring to market its calcitonin salmon injection, a USP synthetic, indicated for treating the symptoms of Paget's bone disease and hypercalcemia. This sterile solution, which is engineered for intramuscular or subcutaneous application, comes in a strength of 200 USP units per mL in a 2 mL multi-dose vial that holds 400 USP units. The product must be kept cool between temperatures of 2°C and 8°C. This injection serves as a calcium regulator and is recommended for treating symptomatic Paget's bone disease when conventional treatments fail to suffice, hypercalcemia, and postmenopausal osteoporosis when other alternatives don't measure up.

What Are the Key Segments in the Calcitonin Injection Market?
The calcitonin injection market covered in this report is segmented -

1) By Type Of Calcitonin: Salmon Calcitonin, Human Calcitonin, Synthetic Calcitonin
2) By Route Of Administration: Intravenous (IV) Injection, Subcutaneous Injection, Intramuscular Injection
3) By Distribution Channel: Direct Sales, Online Pharmacy, Retail Pharmacy, Healthcare Institutions
4) By Therapeutic Application: Osteoporosis Treatment, Pagets Disease Management, Hypercalcemia Control, Bone Metastases Therapy
5) By End-User: Hospitals, Specialty Clinics, Geriatric Care Facilities, Home Healthcare

Subsegments:
1) By Salmon Calcitonin, Synthetic Salmon Calcitonin, Recombinant Salmon Calcitonin
2) By Human Calcitonin, Recombinant Human Calcitonin, Synthetic Human Calcitonin
3) By Synthetic Calcitonin, Peptide-Based Synthetic Calcitonin, Analog Synthetic Calcitonin

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24490&type=smp

Who Are the Key Players Shaping the Calcitonin Injection Market's Competitive Landscape?
Major companies operating in the calcitonin injection market are Kaiser Permanente, F. Hoffmann-La Roche AG, Sanofi S.A., Novartis AG, AstraZeneca plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Viatris Inc., Fresenius Kabi AG, Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Limited, Cipla Limited, Hikma Pharmaceuticals plc, Endo International plc, Asahi Kasei Pharma Corporation, Torrent Pharmaceuticals Limited, BCN Peptides S.L., SG Pharmaceuticals Pvt Ltd, Leucadia Pharmaceuticals Inc., Polypeptide Group AB

What Geographic Markets Are Powering Growth in the Calcitonin Injection Market?
North America was the largest region in the calcitonin injection market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the calcitonin injection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24490

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.